Vivo Opportunity Cayman Fund, L.P.
10% Owner

Vivo Opportunity Cayman Fund, L.P. insider trades: InMed Pharmaceuticals (INM) stock purchases

10% Owner, InMed Pharmaceuticals Last trade Jul 16, 2026 3 Form 4 filings
$0
Sold, last 12 months
0 sales
$434K
Bought, last 12 months
6 buys
6
Open-market trades
since 2026
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vivo Opportunity Cayman Fund, L.P. reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 16, 2026INM↑ Buy$29K
Jul 16, 2026INM↑ Buy$3K
Jul 2, 2026INM↑ Buy$9K
Jul 2, 2026INM↑ Buy$929
Jun 8, 2026INM↑ Buy$356K
Jun 8, 2026INM↑ Buy$36K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other INM insiders

Open-market trades in the last 12 months

About Vivo Opportunity Cayman Fund, L.P.'s insider trades

Vivo Opportunity Cayman Fund, L.P. is a 10% owner of InMed Pharmaceuticals (INM). Since Jun 8, 2026, it has reported 6 open-market purchases worth $434K and no sales on SEC Form 4. In the last 12 months: 6 buys ($434K).

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.